Variant report
Variant | nsv1034110 |
---|---|
Chromosome Location | chr4:167160448-167194968 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000065413 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371543946 | chr4:167176216-167176217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184955389 | chr4:167176275-167176276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551996664 | chr4:167176296-167176297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535702552 | chr4:167176329-167176330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536219708 | chr4:167176331-167176332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6810473 | chr4:167176340-167176341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs569686296 | chr4:167176359-167176360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs448538 | chr4:167176371-167176372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs548266752 | chr4:167176394-167176395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539705936 | chr4:167176395-167176396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs80190415 | chr4:167176453-167176454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188107486 | chr4:167176595-167176596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114836612 | chr4:167176602-167176603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562075541 | chr4:167176606-167176607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371903316 | chr4:167176622-167176623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs180955024 | chr4:167176629-167176630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375701262 | chr4:167176631-167176632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541680654 | chr4:167176640-167176641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563461981 | chr4:167176652-167176653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534191620 | chr4:167176660-167176661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142932857 | chr4:167176684-167176685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116634478 | chr4:167176743-167176744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555764487 | chr4:167176757-167176758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562152871 | chr4:167176822-167176823 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374838542 | chr4:167176824-167176825 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528131620 | chr4:167176834-167176835 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1663600 | chr4:167176845-167176846 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs151082853 | chr4:167176851-167176852 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535502758 | chr4:167176933-167176934 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550905988 | chr4:167176944-167176945 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569389652 | chr4:167176952-167176953 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143734175 | chr4:167176986-167176987 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184748918 | chr4:167177009-167177010 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs71604434 | chr4:167177019-167177020 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558072653 | chr4:167177034-167177035 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1675024 | chr4:167177046-167177047 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs7677325 | chr4:167177101-167177102 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs74321766 | chr4:167177102-167177103 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537970548 | chr4:167177112-167177113 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373490872 | chr4:167177129-167177130 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554234802 | chr4:167177149-167177150 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56797805 | chr4:167177173-167177174 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs574385032 | chr4:167177189-167177190 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146900238 | chr4:167177190-167177191 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368283523 | chr4:167177206-167177207 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546009594 | chr4:167177207-167177208 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564405504 | chr4:167177216-167177217 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147887869 | chr4:167177231-167177232 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546297414 | chr4:167177254-167177255 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78945941 | chr4:167177316-167177317 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:167176200-167176800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:167176800-167177400 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:167179000-167179400 | Enhancers | Placenta | Placenta |
4 | chr4:167184000-167184200 | Bivalent Enhancer | Aorta | Aorta |